Get started
Author

Jennifer L. Wilson

Observed names: Jennifer L. Wilson, Jennifer L Wilson, Jennifer Wilson, Wilson Jennifer, Wilson, Jennifer L.
Observed institutions: University of California, Los Angeles, University of California, San Francisco, Genentech, Stanford Medicine, University of Virginia, Massachusetts Institute of Technology, Stanford University
ORCID: 0000-0002-2328-2018
Observed ORCID: 0000-0002-2328-2018
OpenAlex ID: A5153248045
The influence of prior industry experience and multidisciplinary teamwork on student design learning in a capstone design course
2009 · Kristen Gruenther, Reid Bailey, et al. · Design Studies · 28
Biomarkers: Delivering on the expectation of molecularly driven, quantitative health
2017 · Jennifer L Wilson, Russ B Altman · Experimental Biology and Medicine · 23
PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic development
2018 · Jennifer L. Wilson, Rebecca Racz, et al. · PLoS Computational Biology · 20
PDF
A network paradigm predicts drug synergistic effects using downstream protein–protein interactions
2022 · Jennifer L. Wilson, Ethan Steinberg, et al. · CPT Pharmacometrics & Systems Pharmacology · 16
PDF
Model utility of a deep learning-based segmentation is not Dice coefficient dependent: A case study in volumetric brain blood vessel segmentation
2023 · Mohammadali Alidoost, Vahid Ghodrati, et al. · Intelligence-Based Medicine · 15
Integrated network analyses for functional genomic studies in cancer
2013 · Jennifer L. Wilson, Michael T. Hemann, et al. · Seminars in Cancer Biology · 15
Scientific considerations for global drug development
2020 · Jennifer L. Wilson, Kit Wun Kathy Cheung, et al. · Science Translational Medicine · 12
A computational workflow for assessing drug effects on temporal signaling dynamics reveals robustness in stimulus-specific NFκB signaling
2025 · Emily R. Bozich, Xiaolu Guo, et al. · PLoS Computational Biology · 11
PDF
Controlling astrocyte-mediated synaptic pruning signals for schizophrenia drug repurposing with deep graph networks
2022 · Alessio Gravina, Jennifer L. Wilson, et al. · PLoS Computational Biology · 11
PDF
From random to predictive: a context-specific interaction framework improves selection of drug protein–protein interactions for unknown drug pathways
2022 · Jennifer L Wilson, Alessio Gravina, et al. · Integrative Biology · 11
Harnessing Systems Biology Approaches to Engineer Functional Microvascular Networks
2010 · Lauren S. Sefcik, Jennifer L. Wilson, et al. · Tissue Engineering Part B Reviews · 10
Preclinical side effect prediction through pathway engineering of protein interaction network models
2024 · Mohammadali Alidoost, Jennifer L. Wilson · CPT Pharmacometrics & Systems Pharmacology · 9
An electronic health record cohort of Veterans with amyotrophic lateral sclerosis
2023 · Richard J. Reimer, Andre Goncalves, et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 9
PDF
PathFXweb: a web application for identifying drug safety and efficacy phenotypes
2019 · Jennifer L Wilson, Mike Wong, et al. · Bioinformatics · 8
PhenClust, a standalone tool for identifying trends within sets of biological phenotypes using semantic similarity and the Unified Medical Language System metathesaurus
2021 · Jennifer L Wilson, Mike Wong, et al. · JAMIA Open · 7
PDF
Pathway-based network modeling finds hidden genes in shRNA screen for regulators of acute lymphoblastic leukemia
2016 · Jennifer L. Wilson, Simona Dalin, et al. · Integrative Biology · 7
PDF
Evaluating Angiogenic Potential of Small Molecules Using Genetic Network Approaches
2018 · Anusuya Das, Parker Merrill, et al. · Regenerative Engineering and Translational Medicine · 6
PDF
An in vitro quantitative systems pharmacology approach for deconvolving mechanisms of drug-induced, multilineage cytopenias
2020 · Jennifer L. Wilson, Dan Lu, et al. · PLoS Computational Biology · 5
PDF
Functional Genomics Approach Identifies Novel Signaling Regulators of TGFα Ectodomain Shedding
2017 · Jennifer L. Wilson, Eirini Kefaloyianni, et al. · Molecular Cancer Research · 5
PDF
Beta-2 adrenergic receptor agonism alters astrocyte phagocytic activity and has potential applications to psychiatric disease
2023 · Ellen R. Bowen, Phillip DiGiacomo, et al. · Discover Mental Health · 4
PDF
Three questions to address rigour and reproducibility concerns in your grant proposal
2021 · Jennifer L. Wilson, Crystal M. Botham · Nature · 4
The influence of prior industrial experience and multidisciplinary teamwork on student design learning in a capstone design course
2007 · Kristen Gruenther, Jennifer Wilson, et al. · IEEE Frontiers in Education Conference (FIE) · 4
Uncovering New Therapeutic Targets for Amyotrophic Lateral Sclerosis and Neurological Diseases Using Real‐World Data
2025 · Mohammadali Alidoost, Jeremy Y. Huang, et al. · Clinical Pharmacology & Therapeutics · 2
PDF
Curated and Structure-Based Drug–Target Interactions Improve Underprediction of Drug Side Effects in Network Models
2026 · Mohammadali Alidoost, Amy Le, et al. · Journal of Chemical Information and Modeling · 1
Drug target, class level, and PathFX pathway information share utility for machine learning prediction of common drug-induced side effects
2023 · Han Jie Liu, Jennifer L. Wilson · Frontiers in Drug Safety and Regulation · 1
PDF
Works count: 42
Citation count: 245
H-index: 10
I10-index: 11
Year
Topic
Type